These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10897434)

  • 1. [Specific characteristics of skin basal cell carcinoma invasion].
    Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
    Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
    Barbaud A; Simon M; Parache RM; Serre G
    Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
    Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
    Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of rasGTPase activating protein in basal cell carcinoma of the skin.
    Barshack I; Goldberg I; Davidson B; Ravid A; Schiby G; Kopolovic J; Leviav A; Friedman E
    Mod Pathol; 1998 Mar; 11(3):271-5. PubMed ID: 9521474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of p63 in basal cell carcinomas and association with histological differentiation.
    Bircan S; Candir O; Kapucoglu N; Baspinar S
    J Cutan Pathol; 2006 Apr; 33(4):293-8. PubMed ID: 16630179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
    Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
    Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin profile in basal cell carcinoma.
    Alessi E; Venegoni L; Fanoni D; Berti E
    Am J Dermatopathol; 2008 Jun; 30(3):249-55. PubMed ID: 18496426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomorphological features of cutaneous basal-cell carcinoma].
    Chuprov IN
    Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depth of invasion of basaliomas].
    Breuninger H; Flad P; Rassner G
    Z Hautkr; 1989 Mar; 64(3):191-6. PubMed ID: 2718551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
    Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
    Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
    Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
    J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 alpha-directed invasion of human basal cell carcinoma cells.
    Chu CY; Cha ST; Chang CC; Hsiao CH; Tan CT; Lu YC; Jee SH; Kuo ML
    Oncogene; 2007 Apr; 26(17):2491-501. PubMed ID: 17099730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
    Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
    J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.
    Anthouli-Anagnostopoulou F; Hatziolou E
    Adv Clin Path; 2002 Jan; 6(1):17-24. PubMed ID: 17582944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
    Choi CW; Park HS; Kim YK; Lee SH; Cho KH
    J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas.
    Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I
    J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-affinity nerve growth factor receptor (P75 NGFR) as a marker of perineural invasion in malignant melanomas.
    Chan MM; Tahan SR
    J Cutan Pathol; 2010 Mar; 37(3):336-43. PubMed ID: 19615036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.